Rebetol is the brand name for the antiviral medication ribavirin used primarily in the treatment of chronic hepatitis c. It is formulated as an oral tablet and works by inhibiting the replication of the hepatitis c virus. The active ingredient ribavirin is a synthetic nucleoside analog that interferes with viral rna synthesis. It is converted inside infected cells to ribavate triphosphate which mimics guanosine and leads to premature termination of viral rna chains. This action reduces the amount of viral genetic material that can be produced during infection. In addition ribavirin enhances the antiviral effect when combined with interferon by modulating the host immune response. The combined therapy helps to achieve sustained viral suppression and improves long-term liver outcomes. Overall Rebetol provides a targeted pharmacological approach that limits viral propagation and supports clearance of infection.

Rebetol is a tablet formulation of the antiviral agent ribavirin. It is used to treat chronic hepatitis c infection in adult patients. The active ingredient ribavirin is a synthetic nucleoside analog. Inside infected cells the compound is converted into its active triphosphate form. This active form inhibits the enzyme that synthesizes viral rna. The inhibition prevents the virus from copying its genetic material effectively. By limiting viral replication the medication reduces the amount of virus in the bloodstream. The overall result is a decrease in disease progression and improved liver health.

Rebetol can cause anemia which may result in tiredness and weakness. It is associated with skin rashes and photosensitivity to sunlight. Some patients experience nausea and gastrointestinal discomfort. Elevated liver enzymes are a common laboratory finding during treatment. Mood changes such as irritability or depression have been reported. Headaches and insomnia are also noted as frequent side effects.

Rebetol is an antiviral medication used primarily for chronic hepatitis c infection. Common side effects include fatigue, rash, and nausea. Some patients may experience anemia, which can cause weakness or shortness of breath. Headache and fever are also reported in certain individuals. Serious liver reactions such as elevated transaminases can occur and are monitored regularly. Skin photosensitivity may increase the risk of sunburn when exposed to bright light. Psychiatric symptoms such as irritability or depression have been observed in some cases. Blood tests are typically used during treatment to detect these changes early.